US-based contract research organisation (CRO) Covance has expanded its analytical and stability services facility in Madison, Wisconsin.
The improved US facility, which includes stability chambers equipped with high-density tracked shelving, doubles the CRO’s service capacity for large-scale, long-term stability and release programmes in support of preclinical and clinical as well as chemistry, manufacturing and control (CMC) development for pharmaceutical and animal health products.
Designed to house up to 10 walk-in chambers and several reach-in chambers, the facility also has space for future expansion, the company noted.
“Covance is committed to providing world-class CMC analytical services for our clients to provide the highest quality data and reduce development timelines,” said Henry Hummel, vice president and general manager for the Madison sites.
“Together with our integrated discovery, preclinical and clinical service offerings and dedicated programme management team, we can now offer CMC analytical services as part of an entire molecule development programme.”
